South Rampart Pharma Further Expands Patent Portfolio for SRP-001 with Composition of Matter Patent in China
South Rampart’s global intellectual property portfolio now includes granted patents in the United States, China, India, Japan, Australia, Canada, Brazil, Russia, and Mexico NEW ORLEANS, July 6, 2023 /PRNewswire/ — South Rampart Pharma, Inc. (“South Rampart” or the “Company”), a…
Comments Off on South Rampart Pharma Further Expands Patent Portfolio for SRP-001 with Composition of Matter Patent in China